Mark E. Reynolds
18Patents
7h-index
37Co-inventors
66Inventor score
Filing activity: Sep 26, 1994 → Feb 4, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5532359A | Ras farnesyl transferase inhibitors | Human Necessities | 98 | Expired |
| US6667318B2 | LFA-1 antagonist compounds | Chemistry; Metallurgy | 34 | Expired |
| US5843941A | Ras farnesyl transferase inhibitors | Human Necessities | 32 | Expired |
| US6872735B2 | LFA-1 antagonist compounds | Chemistry; Metallurgy | 29 | Expired |
| US8742076B2 | Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods | Chemistry; Metallurgy | 25 | Active |
| US9492553B2 | Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods | Chemistry; Metallurgy | 8 | Active |
| US7888364B2 | Pyridyl inhibitors of hedgehog signalling | Chemistry; Metallurgy | 7 | Active |
| US8431694B1 | Process for making thienopyrimidine compounds | Chemistry; Metallurgy | 5 | Active |
| US6933314B2 | Integrin receptor inhibitors | Chemistry; Metallurgy | 5 | Expired |
| US6706753B2 | Integrin receptor inhibitors | Chemistry; Metallurgy | 3 | Expired |
| US9278961B2 | Pyridyl inhibitors of hedgehog signalling | Chemistry; Metallurgy | 2 | Active |
| US9321761B2 | Pyridyl inhibitors of hedgehog signalling | Chemistry; Metallurgy | 2 | Active |
| US7893072B2 | Trp-p8 active compounds and therapeutic treatment methods | Chemistry; Metallurgy | 2 | Active |
| US7101851B2 | IgE receptor antagonists | Physics | 2 | Expired |
| US8354528B2 | Process for making thienopyrimidine compounds | Chemistry; Metallurgy | 1 | Active |
| US9790183B2 | Pyridyl inhibitors of hedgehog signalling | Chemistry; Metallurgy | 0 | Active |
| US8785651B2 | Method for manufacturing a boronic acid ester compound | Chemistry; Metallurgy | 0 | Active |
| US7265146B2 | Integrin receptor inhibitors | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.